Top Markets
#1 Glidr Glidr +51.75%
#2 DOVU DOVU +48.15%
#3 Velvet Velvet +34.29%
#4 Black Phoenix Black Phoenix +34.09%
#5 Cross Cross +30.50%
#6 Akedo Akedo +28.62%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +16.95%
#8 QANplatform QANplatform +14.38%
#9 Perle Perle +13.09%
#10 Bitway Bitway +12.53%
Coin of the day
Glidr Glidr
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Lipidor AB (publ) Lipidor AB (publ)

Lipidor AB (publ)

LIPI
Pozycja w akcjach #39102
Lipidor AB (publ), a Swedish pharmaceutical company founded in Danderyd in... Lipidor AB (publ), a Swedish pharmaceutical company founded in Danderyd in 2009, specializes in developing medicinal products. Its core business centers on creating treatments for various skin conditions, including psoriasis, bacterial skin infections, and atopic dermatitis. The company's product pipeline includes AKP-01, which is currently in Phase III clinical trials for psoriasis, while other formulations like AKP-02 (also for psoriasis) and AKP-03 and AKP-07 (for eczema) are in earlier, preclinical development stages. Beyond its own drug candidates, Lipidor manufactures and supplies active pharmaceutical ingredients (APIs). These APIs are incorporated into products addressing a broad spectrum of therapeutic applications, such as managing psoriasis, microbial infections, inflammation, fungal issues, local pain relief, acne, wound healing, eczema, and migraines. Lipidor also caters to the animal health market, offering a line of spray-on skin care products for dogs, cats, and horses. Additionally, it develops consumer health items designed for purposes like antibacterial action, antiseptic care, moisturizing, disinfection, and treating acne and warts. In a key strategic alliance, Lipidor has partnered with Cannassure Therapeutics Ltd. This collaboration aims to advance topical medicinal cannabis products specifically formulated to alleviate skin inflammations and psoriatic lesions.
Cena akcji
$0.02243487
Ostatnia synchronizacja: 2025-06-04
Kapitalizacja rynkowa
$650.09K
Zmiana (1 dzień)
0.39%
Zmiana (1 rok)
0.00%
Kraj
SE
Handel Lipidor AB (publ) (LIPI)

Kategoria

Healthcare
Liczba akcji w obrocie dla Lipidor AB (publ) (LIPI)
Liczba akcji w obrocie na dzień December 2024: 251.84M
Zgodnie z najnowszymi raportami finansowymi i ceną akcji Lipidor AB (publ), aktualna liczba akcji w obrocie to 251.84M. Na koniec December 2023 firma posiadała 28.98M akcji w obrocie. Liczba akcji w obrocie jest zwykle kształtowana przez podziały akcji i skupy akcji.
Historia liczby akcji w obrocie dla Lipidor AB (publ) (LIPI) od 2016 do 2026
Akcje w obrocie na koniec każdego roku
Rok Akcje w obrocie Zmień
2026 (TTM) 251.84M -41.77%
2024 432.53M 1,392.66%
2023 28.98M 0.00%
2022 28.98M 1.83%
2021 28.45M 15.77%
2020 24.58M 21.63%
2019 20.21M 11.87%
2018 18.06M 0.00%
2017 18.06M 0.00%
2016 18.06M 0.00%
Akcje w obrocie dla podobnych firm lub konkurentów
Firma Akcje w obrocie Różnica Kraj
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 892.40M 254.35%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 2.44B 868.92%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 1.77B 603.22%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 796.00M 216.07%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 0.00 -100.00%
US